<DOC>
	<DOCNO>NCT00380445</DOCNO>
	<brief_summary>Please note study conduct United States . The purpose study test hypothesis acute DPP-4 inhibition vildagliptin improve fat muscle metabolism patient type 2 diabetes mellitus .</brief_summary>
	<brief_title>Effect Vildagliptin Fat Muscle Metabolism Patients With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Vildagliptin</mesh_term>
	<criteria>Must able complete 3week washout current antidiabetic medication Can take medication may alter gastric motility except cardiac medication stable dose Must discontinue betablockers lipid lower drug Blood glucose criterion must meet BMI range 3035 History type 1 diabetes , diabetes result pancreatic injury , secondary form diabetes Need insulin within 3 month patient thiazolidinediones Patients take sulfonylurea metformin safely discontinue medication duration study Significant concomitant disease complication diabetes Patients history gastrointestinal surgery positive gastrointestinal symptons High tryglycerides define protocol Smokers abstain smoke treatment period</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Vildagliptin , Type 2 diabetes</keyword>
</DOC>